MedPath

Multimodality Preoperative Evaluation of lymph nodes of perihilar cholangiocarcinoma - a pilot study

Conditions
extrahepatic bile duct cancer
Perihilar cholangiocarcinoma
10019815
Registration Number
NL-OMON49893
Lead Sponsor
Maag-, Darm- en Leverziekten
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

- Presumed resectable pCCA.
- Written informed consent must be given according to ICH/GCP, and
national/local regulations.
- Age > 18 years.

Exclusion Criteria

- Patients with a history of treated pCCA
- Patients with a history of treated liver malignancy
- Patients with a contra-indication for EUS + FNA/FNB (f.e. uncorrectable
coagulopathy or platelet disorder), in line with current clinical practice

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- To evaluate the feasibility of systematic survey of regional and non-regional<br /><br>lymph nodes by EUS-FNA/FNB, defined as:<br /><br>o Number of patients in which all potential lymph node locations were<br /><br>successfully surveyed and FNA/FNB is possible when indicated.</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath